Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell-based immunotherapy.

T G Berger1, E S Schultz

  • 1Department of Dermatology, University of Erlangen, Hartmannstrasse 14, 91052 Erlangen, Germany.

Current Topics in Microbiology and Immunology
|June 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Advanced periocular basal cell carcinoma-a therapeutic challenge].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same author

[Cutaneous diphtheria after a minor injury in Sri Lanka].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2015
Same author

Asthma phenotypes and lung function up to 16 years of age-the BAMSE cohort.

Allergy·2015
Same author

[Disseminated papules in a patient with acute myeloid leukemia].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2010
Same author

Severe exfoliative erythema of malnutrition in a child with coexisting coeliac and Hartnup's disease.

Clinical and experimental dermatology·2008
Same author

[Immunization strategies for treating melanoma].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2008
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Dendritic cell (DC) vaccines show promise for cancer and infectious disease immunotherapy by initiating immune responses. Further research is needed to optimize DC vaccine efficacy and address current limitations.

Area of Science:

  • Immunology
  • Cancer Research
  • Vaccinology

Background:

  • Dendritic cells (DCs) are crucial for initiating cellular immune responses.
  • DC-based vaccines are a promising immunotherapy for cancer and infectious diseases.
  • Clinical trials have shown minor toxicity and induction of antigen-specific T cells and clinical responses in cancer patients.

Purpose of the Study:

  • To review the current state of dendritic cell (DC)-based immunotherapy.
  • To identify key challenges and areas for improvement in DC vaccination strategies.
  • To highlight the importance of understanding DC biology for enhancing therapeutic efficacy.

Main Methods:

  • Review of existing clinical trials and scientific literature on DC-based vaccinations.
  • Analysis of DC biology and its implications for immunotherapy.

Related Experiment Videos

  • Identification of critical factors influencing DC vaccine effectiveness.

    • Main Results:

    • DC-based vaccines have demonstrated potential in inducing immune responses and clinical benefits in cancer patients.
    • Minor toxicity has been reported in clinical trials.
    • Several critical factors require optimization, including antigen loading, DC source, maturation, migration, and vaccination parameters.

    Conclusions:

    • DC-based immunotherapy holds significant promise but is still in early development.
    • Further research focusing on optimizing antigen loading, DC characteristics, and delivery methods is essential.
    • Leveraging advanced knowledge of DC biology is key to improving the efficacy of DC-based therapies.